](https://i.ytimg.com/vi/bHabcAgvFSg/maxresdefault.jpg)
A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.
4 Tampilan
• 07/10/23
0
0
Menanamkan
administrator
Pelanggan
A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.
Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru